PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…
40,388$
1,17%
Echtzeit-Aktienkurs PTC Therapeutics Inc.
Bid:
Ask:
Nachrichten zur PTC Therapeutics Inc. Aktie
Insiderhandel: EXEC. VP AND CLO verkauft Aktien von PTC Therapeutics im Wert von 363.110$
Boulding, Mark Elliott - Vorstand - Tag der Transaktion: 2022-10-17...…
Insiderhandel: EXEC. VP AND CLO verkauft Aktien von PTC Therapeutics im Wert von 16.462$
Boulding, Mark Elliott - Vorstand - Tag der Transaktion: 2022-10-18...…
Reaction Is Overdone For PTC Therapeutics Pausing Huntington Trial Enrollment, Analyst Says
Latest Ratings for PTCT
DateFirmActionFromTo Feb 2022JP MorganMaintainsOverweight Feb 2022BarclaysMaintainsEqual-Weight Oct 2021Raymond JamesMaintainsOutperform
View More…
PTC Therapeutics shares fall 10% after announcing pause in U.S. enrollment for a clinical trial
Shares of PTC Therapeutics Inc. were down 10.1% in trading on Wednesday morning, the day after the company said…
PTC Therapeutics Shares Fall Premarket on U.S. Study Pause >PTCT
PTC Therapeutics Shares Fall Premarket on U.S. Study Pause >PTCT...…
Form 8-K PTC THERAPEUTICS, INC. For: Oct 18
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
PTC Therapeutics falls as partner Roche reports Q3 sales for SMA therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2022 Financial Results
SOUTH PLAINFIELD, N.J., Oct. 13, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host…